Clinical Trial Update: Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cannabis use, self-medication, and agonist treatment in schizophrenia with cannabis use disorder has completed. Results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Schizophrenia

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Schizophrenia, Dual Diagnosis | Phase 1 | Status: COMPLETED | Results posted: 2025-12-09